Friday, February 17, 2012

Codexis CEO Alan Shaw quits, interim boss steps in

Industrial enzyme business Codexis Inc. lost its CEO, Alan Shaw, who quit “to pursue other interests.”
The Redwood City company (NASDAQ: CDXS) named Peter Strumph, senior vice president and head of pharmaceuticals, as interim CEO while it looks for a permanent boss. He worked 10 years at CV Therapeutics before Codexis hired him in 2010.

No comments:

Post a Comment